These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

881 related articles for article (PubMed ID: 25641518)

  • 1. Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease.
    Chen CZ; Ou CY; Yu CH; Yang SC; Chang HY; Hsiue TR
    J Am Geriatr Soc; 2015 Feb; 63(2):244-50. PubMed ID: 25641518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the GOLD 2013 classification in predicting exacerbations and mortality in Taiwanese patients with chronic obstructive pulmonary disease.
    Chen CZ; Ou CY; Hsu CH; Hsiue TR
    J Formos Med Assoc; 2015 Dec; 114(12):1258-66. PubMed ID: 25676673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients.
    Soler-Cataluña JJ; Martínez-García MA; Sánchez LS; Tordera MP; Sánchez PR
    Respir Med; 2009 May; 103(5):692-9. PubMed ID: 19131231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative and predictive properties of multidimensional prognostic indices of chronic obstructive pulmonary disease: a validation study in Taiwanese patients.
    Ou CY; Chen CZ; Yu CH; Shiu CH; Hsiue TR
    Respirology; 2014 Jul; 19(5):694-9. PubMed ID: 24797671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization.
    Johannessen A; Nilsen RM; Storebø M; Gulsvik A; Eagan T; Bakke P
    Am J Respir Crit Care Med; 2013 Jul; 188(1):51-9. PubMed ID: 23590268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.
    Faganello MM; Tanni SE; Sanchez FF; Pelegrino NR; Lucheta PA; Godoy I
    Am J Med Sci; 2010 Jan; 339(1):10-4. PubMed ID: 19926966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ability of Different Scoring Systems to Predict Mortality in Chronic Obstructive Pulmonary Disease Patients: A Prospective Cohort Study.
    Kim J; Lee CH; Hwang SS; Kim DK; Yoon HI; Lee SH; Kim KU; Kim EK; Kim TH; Lee JH; Oh YM; Lee SD
    Respiration; 2019; 98(6):495-502. PubMed ID: 31665736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicomponent indices to predict survival in COPD: the COCOMICS study.
    Marin JM; Alfageme I; Almagro P; Casanova C; Esteban C; Soler-Cataluña JJ; de Torres JP; Martínez-Camblor P; Miravitlles M; Celli BR; Soriano JB
    Eur Respir J; 2013 Aug; 42(2):323-32. PubMed ID: 23222874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The health, activity, dyspnea, obstruction, age, and hospitalization: prognostic score for stable COPD patients.
    Esteban C; Quintana JM; Aburto M; Moraza J; Arostegui I; España PP; Aizpiri S; Capelastegui A
    Respir Med; 2011 Nov; 105(11):1662-70. PubMed ID: 21703842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD.
    Fan VS; Ramsey SD; Make BJ; Martinez FJ
    COPD; 2007 Mar; 4(1):29-39. PubMed ID: 17364675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
    Celli BR; Cote CG; Marin JM; Casanova C; Montes de Oca M; Mendez RA; Pinto Plata V; Cabral HJ
    N Engl J Med; 2004 Mar; 350(10):1005-12. PubMed ID: 14999112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.
    Jones RC; Price D; Chavannes NH; Lee AJ; Hyland ME; Ställberg B; Lisspers K; Sundh J; van der Molen T; Tsiligianni I;
    NPJ Prim Care Respir Med; 2016 Apr; 26():16010. PubMed ID: 27053297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index.
    Puhan MA; Garcia-Aymerich J; Frey M; ter Riet G; Antó JM; Agustí AG; Gómez FP; Rodríguez-Roisín R; Moons KG; Kessels AG; Held U
    Lancet; 2009 Aug; 374(9691):704-11. PubMed ID: 19716962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.
    Gedebjerg A; Szépligeti SK; Wackerhausen LH; Horváth-Puhó E; Dahl R; Hansen JG; Sørensen HT; Nørgaard M; Lange P; Thomsen RW
    Lancet Respir Med; 2018 Mar; 6(3):204-212. PubMed ID: 29331311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Indices and Mortality Prediction in COPD Caused by Biomass Smoke Exposure.
    Golpe R; Mengual-Macenlle N; Sanjuán-López P; Cano-Jiménez E; Castro-Añón O; Pérez-de-Llano LA
    Lung; 2015 Aug; 193(4):497-503. PubMed ID: 25926292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the GOLD 2017 and new 16 subgroups (1A-4D) classifications in predicting exacerbation and mortality in COPD patients.
    Han MZ; Hsiue TR; Tsai SH; Huang TH; Liao XM; Chen CZ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3425-3433. PubMed ID: 30425472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does high-frequency chest wall oscillation therapy have any impact on the infective exacerbations of chronic obstructive pulmonary disease? A randomized controlled single-blind study.
    Goktalay T; Akdemir SE; Alpaydin AO; Coskun AS; Celik P; Yorgancioglu A
    Clin Rehabil; 2013 Aug; 27(8):710-8. PubMed ID: 23503735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population.
    Lange P; Marott JL; Vestbo J; Olsen KR; Ingebrigtsen TS; Dahl M; Nordestgaard BG
    Am J Respir Crit Care Med; 2012 Nov; 186(10):975-81. PubMed ID: 22997207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.
    Casanova C; Marin JM; Martinez-Gonzalez C; de Lucas-Ramos P; Mir-Viladrich I; Cosio B; Peces-Barba G; Solanes-García I; Agüero R; Feu-Collado N; Calle-Rubio M; Alfageme I; de Diego-Damia A; Irigaray R; Marín M; Balcells E; Llunell A; Galdiz JB; Golpe R; Lacarcel C; Cabrera C; Marin A; Soriano JB; Lopez-Campos JL; Soler-Cataluña JJ; de-Torres JP;
    Chest; 2015 Jul; 148(1):159-168. PubMed ID: 25612228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.